Efgartigimod alfa Interactions
There are 282 drugs known to interact with efgartigimod alfa, along with 2 disease interactions. Of the total drug interactions, 44 are major, 231 are moderate, and 7 are minor.
- View all 282 medications that may interact with efgartigimod alfa
- View efgartigimod alfa disease interactions (2)
Most frequently checked interactions
View interaction reports for efgartigimod alfa and the medicines listed below.
- Augmentin (amoxicillin / clavulanate)
- Benadryl (diphenhydramine)
- CellCept (mycophenolate mofetil)
- Crestor (rosuvastatin)
- Effexor (venlafaxine)
- Emgality (galcanezumab)
- Ezfe (iron polysaccharide)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Gammaked (immune globulin intravenous and subcutaneous)
- Gammaplex (immune globulin intravenous)
- Humulin R U-500 KwikPen (insulin regular)
- L-Arginine (arginine)
- Lexapro (escitalopram)
- Lipitor (atorvastatin)
- Lomotil (atropine / diphenoxylate)
- Lortab (acetaminophen / hydrocodone)
- Mestinon (pyridostigmine)
- Mestinon Timespan (pyridostigmine)
- Morphine Sulfate ER (morphine)
- NAC (acetylcysteine)
- Naproxen Sodium DS (naproxen)
- NasalCrom (cromolyn nasal)
- Nexium (esomeprazole)
- Ozempic (semaglutide)
- Pepcid Complete (calcium carbonate / famotidine / magnesium hydroxide)
- Pepto-Bismol (bismuth subsalicylate)
- Percocet (acetaminophen / oxycodone)
- Quercetin (bioflavonoids)
- Silvadene Cream 1% (silver sulfadiazine topical)
- Sudafed Congestion (pseudoephedrine)
Efgartigimod alfa disease interactions
There are 2 disease interactions with efgartigimod alfa which include:
More about efgartigimod alfa
- efgartigimod alfa consumer information
- Compare alternatives
- Reviews (9)
- Side effects
- Dosage information
- During pregnancy
- Drug class: immune globulins
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.